- SL12 ≥ 0
- MACDhist ≥ 0
- If conditions not met → Invest in cash equivalent (SHV)
Portfolio Construction: Linear Regression Based Strategy
Selection Summary
Step 1: SLmean
58
Top 50% Selected
threshold: 0.0120
Step 2: RSmean
19
Top 33% Selected
threshold: 0.8345
Step 3: Corr
4
Bottom 25% Selected
threshold: 0.3299
Final Portfolio
4
Final Selected Holdings
Portfolio Visualization
Criteria: RSmean (x-axis) | SLmean (y-axis)
Reference lines: Horizontal SLmean threshold, Vertical RSmean threshold
Investment Filter
Momentum Strategy Condition Verification and Investment Allocation
Selected Stocks
4
Step 3 Result
Actual Investment
4
Stocks Meeting Conditions
SHV (Cash)
0.0%
Unqualified Allocation
Investment Criteria
| Ticker | Name | SLmean | RSmean | Corr | SL12 | MACDhist | Allocation | Invest_Target | Reason |
|---|---|---|---|---|---|---|---|---|---|
| COLO | Global X MSCI Colombia ETF | 0.048 | 0.949 | 0.086 | 0.033 | 3.449 | 25.0% | COLO | None |
| IBB | iShares Biotechnology ETF | 0.056 | 0.904 | 0.140 | 0.024 | 2.879 | 25.0% | IBB | None |
| AMLP | Alerian MLP ETF | 0.021 | 0.927 | 0.177 | 0.021 | 1.030 | 25.0% | AMLP | None |
| EPOL | iShares MSCI Poland ETF | 0.026 | 0.907 | 0.330 | 0.029 | 2.057 | 25.0% | EPOL | None |
Portfolio Holdings
Detailed information on 4 finally selected holdings.
| Ticker | Name | Price | SL12 | MRmean | RS12 | RSmean | RS1 | RS3 | RS6 | Corr | MR1 | MR3 | MR6 | MR12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COLO | Global X MSCI Colombia ETF | 48.480 | 0.033 | 0.284 | 0.862 | 0.949 | 1.000 | 0.975 | 0.772 | 0.086 | 0.043 | 0.244 | 0.251 | 0.598 |
| IBB | iShares Biotechnology ETF | 208.950 | 0.024 | 0.261 | 0.773 | 0.904 | 1.000 | 0.828 | 0.685 | 0.140 | 0.121 | 0.214 | 0.193 | 0.516 |
| AMLP | Alerian MLP ETF | 55.240 | 0.021 | 0.110 | 0.882 | 0.927 | 1.000 | 0.896 | 0.678 | 0.177 | 0.017 | 0.091 | 0.103 | 0.228 |
| EPOL | iShares MSCI Poland ETF | 43.480 | 0.029 | 0.168 | 0.934 | 0.907 | 1.000 | 0.621 | 0.765 | 0.330 | 0.015 | 0.081 | 0.149 | 0.428 |